Lucke T W, Hole D J, Mackie R M
Department of Dermatology, University of Glasgow, U.K.
Br J Dermatol. 1997 Nov;137(5):761-3.
The incidence of basal cell carcinoma and squamous cell carcinoma (non-melanoma skin cancer) is increasing in the U.K., and the importance of this has been recognized in the 'Health of the Nation' target of halting the annual increase in the incidence of skin cancer by the year 2005. An accurate assessment of incidence is necessary both in meeting this target and in planning skin cancer services. We have examined the ways in which basal cell carcinoma and squamous cell carcinoma are diagnosed and treated in Greater Glasgow and have determined how many of these tumours are, recorded by the West of Scotland Cancer Registry. Our results show that there is under-registration of both basal cell carcinoma and squamous cell carcinoma. Overall, 39 of 127 basal cell carcinomas (31%; 95% confidence interval [CI] 23-39%) and 11 of 25 squamous cell carcinomas (44%; CI 26-63%) were not registered by the cancer registry. We also showed that dermatologists rarely treat clinically suspicious tumours without obtaining pathological proof of the diagnosis. Accurate data collection by selected representative cancer registries is suggested as a possible solution.
在英国，基底细胞癌和鳞状细胞癌（非黑素瘤皮肤癌）的发病率正在上升，这一点在“国家健康”目标中得到了认可，该目标是到2005年阻止皮肤癌发病率的逐年上升。准确评估发病率对于实现这一目标以及规划皮肤癌服务都很有必要。我们研究了大格拉斯哥地区基底细胞癌和鳞状细胞癌的诊断和治疗方式，并确定了苏格兰西部癌症登记处记录的此类肿瘤数量。我们的结果表明，基底细胞癌和鳞状细胞癌均存在登记不足的情况。总体而言，127例基底细胞癌中有39例（31%；95%置信区间[CI]为23 - 39%），25例鳞状细胞癌中有11例（44%；CI为26 - 63%）未被癌症登记处登记。我们还表明，皮肤科医生在未获得病理诊断证据的情况下，很少会治疗临床可疑肿瘤。建议由选定的具有代表性的癌症登记处进行准确的数据收集，作为一种可能的解决方案。
